SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-286262
Filing Date
2023-11-30
Accepted
2023-11-30 16:05:20
Documents
11
Effectiveness Date
2023-11-30

Document Format Files

Seq Description Document Type Size
1 S-3ASR d614767ds3asr.htm S-3ASR 184817
2 EX-4.2 d614767dex42.htm EX-4.2 92992
3 EX-5.1 d614767dex51.htm EX-5.1 6725
4 EX-10.1 d614767dex101.htm EX-10.1 210057
5 EX-23.1 d614767dex231.htm EX-23.1 3783
6 EX-FILING FEES d614767dexfilingfees.htm EX-FILING FEES 19557
7 GRAPHIC g61476745aa.jpg GRAPHIC 8374
8 GRAPHIC g61476745bb.jpg GRAPHIC 6676
9 GRAPHIC g614767dsp82aa.jpg GRAPHIC 3840
10 GRAPHIC g614767dsp82b.jpg GRAPHIC 2904
11 GRAPHIC g614767g1128110109197.jpg GRAPHIC 2980
  Complete submission text file 0001193125-23-286262.txt   554148
Mailing Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BLDG. 17, SUITE 401 WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-275805 | Film No.: 231455713
SIC: 8071 Services-Medical Laboratories